Could Johnson & Johnson’s $5.5bn talc deal finally close a 15-year legal overhang?
Johnson & Johnson proposes a $5.5 billion deal for 76,000 ovarian talc claims, but participation, future lawsuits and costs remain critical.
Pharma & Biotech